Suprabasin as a novel tumor endothelial cell marker

Cancer Sci. 2014 Dec;105(12):1533-40. doi: 10.1111/cas.12549. Epub 2014 Nov 5.

Abstract

Recent studies have reported that stromal cells contribute to tumor progression. We previously demonstrated that tumor endothelial cells (TEC) characteristics were different from those of normal endothelial cells (NEC). Furthermore, we performed gene profile analysis in TEC and NEC, revealing that suprabasin (SBSN) was upregulated in TEC compared with NEC. However, its role in TEC is still unknown. Here we showed that SBSN expression was higher in isolated human and mouse TEC than in NEC. SBSN knockdown inhibited the migration and tube formation ability of TEC. We also showed that the AKT pathway was a downstream factor of SBSN. These findings suggest that SBSN is involved in the angiogenic potential of TEC and may be a novel TEC marker.

Keywords: Angiogenesis; suprabasin; suprabasin signaling; tumor endothelial cell marker; tumor endothelial cells.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antigens, Differentiation / genetics
  • Antigens, Differentiation / metabolism*
  • Biomarkers, Tumor / metabolism
  • Cell Line, Tumor
  • Endothelial Cells / metabolism
  • Endothelial Cells / pathology*
  • Gene Expression Profiling
  • Gene Expression Regulation, Neoplastic
  • Gene Knockdown Techniques
  • Humans
  • Mice
  • Mice, Nude
  • Neoplasm Metastasis / pathology
  • Neoplasm Proteins / genetics
  • Neoplasm Proteins / metabolism*
  • Neoplasms / metabolism
  • Neoplasms / pathology*
  • Neovascularization, Pathologic / metabolism
  • Signal Transduction

Substances

  • Antigens, Differentiation
  • Biomarkers, Tumor
  • Neoplasm Proteins
  • SBSN protein, human
  • suprabasin protein, mouse